Welcome : Guest

Roche Holding AG (Switzerland) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Roche Holding AG, which is principally a Research-based Healthcare Company. Illustrated with 140 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-00024
Price: $3500
Company Type: Public
Pages: 143
Date: January 2017
Market Data Tables: 140

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Roche Holding AG’s Sales by Business Segment (2014-2015) in Percentage for Pharmaceuticals, and Diagnostics......3
Pharmaceuticals......4
Table 2: Pharma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Injectables, Oral Solids, Tropicals and Others......4
Table 3: Pharmaceutical Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for China, Japan, USA and Others......5
Table 4: Pharmaceuticals Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia, Africa, and Australasia, European Union, Japan, Latin America, and North America......6
Table 5: Pharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Generic, Originator Brand, and Others......7
Table 6: Pharmaceuticals Sales by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Active Pharmaceutical Ingredients, Contrast Products, Radiopharmaceuticals, and Specialty Pharmaceuticals......8
Table 7: Pharmaceuticals Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics and Chemical Synthetic and Others......9
Table 8: New Pharmaceutical Licensed Drugs Market by Indication Worldwide (2015) - Percentage Share Breakdown by Value Sales for AIDS, Diabetes, Diabetes (DPP4), Hepatitis B, Hypertension, and Others......10
Table 9: New Pharmaceutical Licensed Drugs Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Humulin, Trajenta, Truvada, Twynsta, Viread, and Others......11
Table 10: Emerging Market Pharma Sales by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for Africa & Middle East, Brazil, China, India, Russia, and Others......12
Table 11: Research & Development Spending in Pharmaceuticals by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Approval, Discovery, Pre-Clinical, Phase I, Phase II, Phase III, Phase IV, and Others......13
Table 12: Pharmaceutical Consumption by Category in Australia (2015) - Percentage Share Breakdown for Aged over 65 Years, and Aged under 65 Years......14
Table 13: Pharmaceutical Market by Region in Brazil (2015) - Percentage Share Breakdown by Value Sales for Mid-West, North, Northeast, São Paulo, South, and Others......15
Table 14: Pharmaceutical Sales by Category in Brazil (2015) - Percentage Share Breakdown by Value for Generics, Over the Counter (OTC) Drugs, and Prescription......16
Table 15: Pharmaceutical Market by Category in Canada (2015) - Percentage Share Breakdown by Value for Hospital and Retail......17
Table 16: Pharmaceutical Distribution Market by Region in China (2015) - Percentage Share Breakdown by Value for Eastern China, North East China, Northern China, Northwestern China, Southern China, and Southwestern China......18
Table 17: Pharmaceuticals Market by Therapeutic Area in China (2015) - Percentage Share Breakdown by Value Sales for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular Diseases, Musculo-Skeletal System, Nervous System, Oncology, Respiratory System, Systemic Anti- Infective, and Others......19
Table 18: Pharmaceutical Market by Country in Europe (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Greece, Italy, Spain, UK, and Others......20
Table 19: Pharmaceutical Drugs Market by Category in Germany (2015) - Percentage Share Breakdown by Value Sales for Biopharmaceuticals, Pharma Drugs for Human Use, and Others......21
Table 20: Pharma Market by Category in Indonesia (2015) - Percentage Share Breakdown by Value for Branded Generics and Licensed, Over the Counter and Unbranded Generics......22
Table 21: Pharmaceutical Market by Region in Latin America (2015) - Percentage Share Breakdown by Value for Argentina, Brazil, Mexico, Venezuela and Others......23
Table 22: Retail Pharmaceutical Market by Type in Mexico (2015) - Percentage Share Breakdown by Value for Private Market and Public Market......24
Table 23: Spending on Pharmaceutical by Category in Nigeria (2015) - Percentage Share Breakdown by Value for Generic Drug Sales, Over-The-Counter Medicine Sales and Patented Drug Sales......25
Table 24: Private Pharmaceuticals Market by Segment in South Africa (2015) - Percentage Share Breakdown by Value for Branded and Ethical, Generic, Over the Counter and Others......26
Table 25: Pharmaceutical Drugs Manufacturers by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Biological Products, Medicinal and Botanical Products, Oncological Products, and Others......27
Table 26: Speciality Pharmaceuticals Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......28
Table 27: Pharmaceutical Market by Category in Vietnam (2015) - Percentage Share Breakdown by Value for Generic Drugs, Patented Drugs and Others......29
Cancer......30
Table 28: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......30
Table 29: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......31
Table 30: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......32
Table 31: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......33
Table 32: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......34
Table 33: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......35
Table 34: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......36
Table 35: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......37
Table 36: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......38
Table 37: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......39
Table 38: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......40
Table 39: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......41
Table 40: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......42
Table 41: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......43
Anti-Cancer Drugs......44
Table 42: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......44
Table 43: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......45
Bladder Cancer......46
Table 44: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......46
Breast Cancer......47
Table 45: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......47
Cervical Cancer......48
Table 46: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......48
Table 47: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......49
Colorectal Cancer......50
Table 48: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......50
Hematological Cancer......51
Table 49: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......51
Invasive Breast Cancer......52
Table 50: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......52
Table 51: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......53
Primary Liver Cancer......54
Table 52: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......54
Skin Cancer......55
Table 53: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......55
Cancer in Stage 3/4......56
Table 54: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......56
Solid Cancer Tumor Patients......57
Table 55: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......57
Cancer-Associated Mucositis......58
Table 56: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......58
Cancer Drugs......59
Table 57: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......59
Chronic Lymphocytic Leukemia (CLL)......60
Table 58: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......60
Table 59: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......61
Table 60: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......62
Chronic Myelogenous Leukemia (CML)......63
Table 61: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......63
Cutaneous Melanoma......64
Table 62: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......64
Ocular Melanoma......65
Table 63: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......65
Female Mortality......66
Table 64: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine,Liver, and Others......66
Male Mortality......67
Table 65: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......67
Nausea and Vomiting Associated With Cancer Chemotherapy......68
Table 66: Nausea and Vomiting Associated With Cancer Chemotherapy Market by Drug in European Union (2015) - Percentage Share Breakdown by Value for Aprepitant (Emend), Netupitant (Akynzeo), and Rolapitant (Varubi)......68
Multiple Myeloma......69
Table 67: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......69
Table 68: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......70
Non Small Cell Lung Cancer Patients......71
Table 69: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......71
Immunology......72
Table 70: Immunology Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Dermatology, Gastroenterology, and Rheumatology......72
Tissue Diagnostics......73
Table 71: Tissue Diagnostics Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Advanced Staining, Advanced Work Flow, Preanalytical, Primary Staining, Primary Staining, and Special Stains......73
Diabetes Care......74
Table 72: Diabetes Care Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Human Insulins, Modern Insulins, Victoza, and Others......74
Blood Screening Tests......75
Table 73: Blood Screening Test Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Commercial West Nile Virus, Tigris/Spare Parts to Chiron at Cost, Ultrio/Procleix Blood Screening, and Others......75
Biotechnology......76
Table 74: Biotechnology Market by Category in China (2015) - Percentage Share Breakdown by Value for Biopharmaceutical and Chemical......76
Table 75: Biotechnology Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biopharmaceutical and Chemical......77
Pharmaceuticals......78
Table 76: Market Shares of Leading Pharmaceutical Companies in Australia (2015) - Percentage Share Breakdown by Value for AstraZeneca, Pfizer, Inc. and Others......78
Table 77: Market Shares of Leading Pharmaceutical Distributors in Brazil (2015) - Percentage Share Breakdown by Value for Panpharma Participacoes S.A., Profarma Distribuidora de Produtos Farmaceuticos S.A., Santa Cruz and Others......79
Table 78: Market Shares of Leading Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma Tbk., Pfizer Indonesia PT Tbk, Sanbe Farma PT, and Others......80
Table 79: Market Shares of Leading Pharmaceutical Suppliers to Hospitals in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma, Tbk, Sanbe Farma PT, Soho Group, and Others......81
Table 80: Market Shares of Leading Pharmaceutical Drugs Manufacturers in the US (2015) - Percentage Breakdown by Value for Amgen, Eli Lilly and Co., Johnson and Johnson Co, Merck & Co., Inc., Pfizer, Inc., and Others......82
Table 81: Market Shares of Leading Pharmaceutical Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Abbott Laboratories, Amgen Corporation, AstraZeneca Plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......83
Cancer Drugs......84
Table 82: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......84
Table 83: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......85
Table 84: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......86
Breast Cancer Drugs......87
Table 85: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......87
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......88
Table 86: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......88
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......89
Table 87: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......89
Table 88: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......90
Diabetes Care......91
Table 89: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......91
Tissue Diagnostics Equipment......92
Table 90: Market Shares of Leading Tissue Diagnostics Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Dako Group, Danaher Corporation, F. Hoffmann-La Roche AG, Sakuro FineTek, Inc., Thermo Fisher Scientific, and Others......92
Molecular Diagnostics......93
Table 91: Market Shares of Leading Molecular Diagnostics (MDx) Companies by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Co., Cepheid, F. Hoffmann-La Roche Ltd., Hologic Gen-Probe, Inc., Novartis AG, Qiagen N.V., Siemens AG and Others......93
Table 92: Market Shares of Leading Molecular Diagnostic Product Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic Corporation, Novartis International AG, Qiagen, and Others......94
Table 93: Market Shares of Leading Molecular Diagnostics (MDx) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Inc., Hologic, Inc., Illumina, Inc., Qiagen N.V., Rogers Corporation, Siemens AG, Thermo Fisher Scientific, and Others......95
Biotechnology......96
Table 94: Market Shares of Leading Agricultural Biotechnology Companies Worldwide (2015) - Percentage Breakdown by Research and Development (R&D) Expenditure for Bayer CropScience AG, Dow AgroSciences LLC, DuPont Pioneer, Monsanto Co., Inc., Syngenta AG and Others......96
Drugs of Abuse Testing (DOA) Testing Equipment......97
Table 95: Market Shares of Leading Drugs of Abuse Testing (DOA) Testing Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bec World PLC (BEC), Danaher Corporation (DHR), Microgenics Corporation, Roche Holding AG, Siemens AG (SI), and Others......97
Insulin Pump & Supplies......98
Table 96: Market Shares of Leading Insulin Pump & Supplies Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for Insulet Corporation, Johnson & Johnson, Medtronic Plc, Roche Holding AG, and Tandem Diabetes Care, Inc.......98
Diabetes Insulin Pump......99
Table 97: Market Shares of Leading Diabetes Insulin Pump Suppliers Worldwide (2015) - Percentage Breakdown by Value for Animas Corporation, Diabetes Multi-Disciplinary Team, Pragmatic Organisation Dynamic Display, Roche Holding AG, and Tandem Diabetes Care, Inc.......99
Blood Gas Analyser......100
Table 98: Market Shares of Leading Blood Gas Analyser Companies Worldwide (2015) - Percentage Breakdown by Value for Abbott Laboratories, Instrumentation Laboratories, Radiometer, Roche Holding AG, Siemens AG, and Others......100
Blood Glucose Monitoring......101
Table 99: Market Shares of Leading Blood Glucose Monitoring Product Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, Bayer AG, Johnson & Johnson, Roche Holding AG, and Others......101
Biologic Drug......102
Table 100: Market Shares of Leading Biologic Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Value for AbbVie Inc., Amgen, Inc. and Pfizer, Inc., Johnson & Johnson, Roche Holding AG and Others......102
Human Growth Hormones (HGH)......103
Table 101: Market Shares of Leading Human Growth Hormones (HGH) Producers Worldwide (2015) - Percentage Breakdown by Value for Eli Lilly and Company (Humatrope), Merck KGaA (Saizen,Serostim), Novo Nordisk A/S (Norditropin), Pfizer Inc. (Genotropin), Roche Holding AG (Nutropin), Teva Pharmaceutical Industries Ltd. (Tev-Tropin) and Others......103
Table 102: Market Shares of Leading Human Growth Hormones (HGH) Producers in the US (2015) - Percentage Breakdown by Value for Eli Lilly and Company, Genentech, Inc. and Roche Holding AG, Merck KGaA, Novartis International AG, Novo Nordisk A/S, Pfizer, Inc. and Teva Pharmaceutical Industries Ltd.......104
Biotechnology......105
Table 103: Market Shares of Leading Biotechnology Companies Worldwide (2015) - Percentage Breakdown by Value for Amgen, Inc., Merck KGaA, Monsanto Company, Roche Holding AG, Syngenta AG, and Others......105
Table 104: Market Shares of Leading Biotechnology Companies in China (2015) - Percentage Share Breakdown by Value for F. Hoffmann-La Roche Ltd., MERCK SERONO CO., LTD., Novo Nordisk A/S, Qilu Pharmaceutical Co., Ltd. and Others......106
Advanced Staining Solutions......107
Table 105: Market Shares of Leading Advanced Staining Solutions Providers Worldwide (2015) - Percentage Breakdown by Value for Abbott Laboratories, Dako, Leica Camera AG, Roche Holding AG and Ventana Medical Systems, Inc., and Others......107
RX Pharmaceuticals......108
Table 106: Market Shares of Leading RX Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Eurofarma Laboratórios, Hypermarcas S.A.,Pfizer, Inc., Roche AG, Sanofi - Medley Indústria Farmacêutica Ltda and Others......108
Growth Hormone......109
Table 107: Market Shares of Leading Growth Hormone Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Eli Lilly and Company (humatrope), Novo Nordisk (Norditropin), Pfizer, Inc. (Genotropin), Roche Holdings AG (Nutropin) and Others......109
Next-Generation Sequencing (NGS) Instruments......110
Table 108: Market Shares of Leading Next-Generation Sequencing (NGS) Instrument Manufacturers Worldwide (2015) - Percentage Breakdown by Value for F. Hoffmann-La Roche AG, Illumina, Inc., Pacific Biosciences of California, Inc. and Others......110
Immunology Testing......111
Table 109: Market Shares of Leading Immunology Testing Providers in the US (2015) - Percentage Breakdown by Value for Abbott India Ltd., Beckman Coulter Inc., Johnson & Johnson, Roche AG, Siemens AG, and Others......111
Biochemistry Analyzers......112
Table 110: Market Shares of Leading Biochemistry Analyzers Manufacturers in the US (2015) - Percentage Breakdown by Value for Abbott India Ltd., Beckman Coulter, Inc., Johnson & Johnson, Roche AG, Siemens AG, and Others......112
Viral Load Testing Equipment......113
Table 111: Market Shares of Leading Viral Load Testing Equipment Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for BioMerieux, F. Hoffmann-La Roche AG, Siemens Healthcare, and Others......113
Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Testing......114
Table 112: Market Shares of Leading Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Testing Providers in the US (2014) - Percentage Breakdown by Value Sales for Abbott Laboratories, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Hologic, Inc., and Qiagen NV......114
Professional Diagnostic Equipment......115
Table 113: Market Shares of Leading Professional Diagnostic Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories (ABT), Alere, Inc. (ALR), BioMerieux SA (BIM), Danaher Corporation (DHR), F. Hoffmann-La Roche AG, Johnson & Johnson, Siemens AG (SIE), and Others......115
Neisseria Gonorrhoeae (GC)/Chalamydia Trachomatis (CT)......116
Table 114: Market Shares of Leading Neisseria Gonorrhoeae (GC)/Chalamydia Trachomatis (CT) Testing Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Becton, Dickinson and Company (BDX), Cepheid, Inc. (CPHD), F.Hoffmann-La Roche AG, Hologic, Inc. (HOLX), Qiagen N.V. (QGEN), and Others......116
Hepatitis B Drug......117
Table 115: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bemis Company, Inc.(Baraclude), F. Hoffmann-La Roche AG (Pegasys), GlaxoSmithKline Plc (Hepsera, Zeffix), and Novartis International AG (Sebivo)......117
In Vitro Diagnostics (IVD)......118
Table 116: Market Shares of Leading In-Vitro Diagnostics (IVD) Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Abbott Healthcare Pvt. Ltd., Alere, Inc., Danaher Corporation, LifeScan, Inc., Roche Holdings, Inc., System Industrie Electronic GmbH, Thermo Fisher Scientific, Inc., and Others......118
Table 117: Market Shares of Leading In-Vitro Diagnostics (IVD) Manufacturers in China (2015) - Percentage Breakdown by Value Sales for Abbott Healthcare Pvt. Ltd., Mindray Medical International Limited, Roche Holdings, Inc., and Others......119
Table 118: Market Shares of Leading In Vitro Diagnostics (IVDs) Companies in the US (2014) - Percentage Share Breakdown by Value for Abbott Laboratories, BioMérieux, Danaher Corporation, The, F. Hoffmann-La Roche AG, Johnson & Johnson, Siemens AG, and Others......120
Bone Diseases Therapeutic......121
Table 119: Market Shares of Leading Bone Diseases Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Amgen, Inc., Eli Lilly and Company, GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, Sanofi S.A., and Others......121
Cardiology Therapeutic......122
Table 120: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......122
HBV/HCV Therapeutics......123
Table 121: Market Shares of Leading HBV/HCV Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., and Others......123
Infectious Disease Drugs......124
Table 122: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......124
Obesity Therapeutics......125
Table 123: Market Shares of Leading Obesity Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, and Others......125
Ophthalmology Therapeutics......126
Table 124: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......126
Respiratory Therapeutic......127
Table 125: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......127
Rheumatology Therapeutic......128
Table 126: Market Shares of Leading Rheumatology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......128
Therapeutic Providers......129
Table 127: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......129
STD Testing......130
Table 128: Market Shares of Leading STD Testing Companies by Value Sales Worldwide (2015) - Percentage Breakdown for Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Gen-Probe, Inc., and Others......130
Blood Screening Test......131
Table 129: Market Shares of Leading Blood Screening Test Companies by Value Sales Worldwide (2015) - Percentage Breakdown for F. Hoffmann-La Roche AG, Gen-Probe, Inc., and Others......131
Monoclonal Antibodies......132
Table 130: Market Shares of Leading Monoclonal Antibody Production Companies in the US (2015) - Percentage Share Breakdown by Value for Abbvie Inc., AMGen, Johnson & Johnson, F. Hoffmann-La Roche AG and Others......132
Blood Gas Analyser......133
Table 131: Market Shares of Leading Blood Gas Analyser Companies Worldwide (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, F. Hoffmann-La Roche AG, Instrumentation Laboratory Company, Radiometer India, Siemens AG, and Others......133
Blood Glucose Diagnostics Equipment......134
Table 132: Market Shares of Leading Blood Glucose Diagnostics Equipment Manufacturers by Value Sales Worldwide (2015) - Percentage Breakdown for Abbott Laboratories, Bayer AG, F. Hoffmann-La Roche AG, LifeScan, Inc., and Others......134
Molecular Methicillin-resistant Staphylococcus aureus (MRSA)/SA Equipment......135
Table 133: Market Shares of Leading Molecular Methicillin-Resistant Staphylococcus Aureus (MRSA)/SA Diagnostic Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Becton Dickinson and Co., Cepheid, Inc., F. Hoffmann-La Roche AG, and Others......135
Molecular Chlamydia trachomatis (CT)/Neisseria gonorrhoeae (NG) Equipment......136
Table 134: Market Shares of Leading Molecular Chlamydia Trachomatis (CT)/Neisseria Gonorrhoeae (NG) Diagnostic Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories, Becton, Dickinson and Company, Cepheid, Inc., F. Hoffmann-La Roche AG, Hologic Corporation, Qiagen N.V., and Others......136
Molecular Human Papillomavirus (HPV) Equipment......137
Table 135: Market Shares of Leading Molecular Human Papillomavirus (HPV) Diagnostic Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Hologic Corporation, Qiagen N.V., and Others......137
Table 136: F. Hoffmann-La Roche AG's Sales by Region Worldwide (2014) - Percentage Share Breakdown by Value for Europe, International, Japan, and US......138
Table 137: F. Hoffmann-La Roche AG's Sales by Product Worldwide (2014) - Percentage Share Breakdown by Value for Diagnostics, and Pharmaceuticals......139
Table 138: Roche’s Sales by Geographic Region Worldwide (2013) in Percentage for USA, Europe, Japan, and Others......140
Table 139: Roche’s Sales by Products Worldwide (2013) in Percentage for Pharmaceuticals Division and Diagnostics Division......141
Table 140: Roche’s Sales by Product Segment Worldwide (2013) in Percentage for Pharmaceuticals and Diagnostics......142